Allergan Officially Adds Coolsculpting to Portfolio
04/27/2017
It’s a done deal.
Allergan now owns ZELTIQ® Aesthetics.
Allergan acquired ZELTIQ® Aesthetics for approximately $2.4 billion in cash.
ZELTIQ® stockholders approved the transaction during its stockholder meeting held on April 27, 2017. With the acquisition, Allergan adds ZELTIQ's flagship CoolSculpting® System to their portfolio.